Implanted pump offers hope for easier pulmonary hypertension treatment
NCT ID NCT01321073
Summary
This study tested the safety of a fully implantable pump system designed to deliver medication directly into the bloodstream for people with pulmonary arterial hypertension (PAH). The system aimed to provide more convenient, long-term treatment while reducing infection risks compared to external pumps. The study focused on patients who were already using this experimental system and needed continued medical support.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AdventHealth Orlando
Orlando, Florida, 32803, United States
-
Aurora St. Lukes Medical Center
Milwaukee, Wisconsin, 53234, United States
-
Brigham & Women's Hospital
Boston, Massachusetts, 02115, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
-
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390-7208, United States
-
VA Greater Los Angeles Healthcare System
Los Angeles, California, 90073, United States
Conditions
Explore the condition pages connected to this study.